IL127287A - Use of tetrasil ver tetroxide molecular crystals in the preparation of a medicament for treatment of aids - Google Patents

Use of tetrasil ver tetroxide molecular crystals in the preparation of a medicament for treatment of aids

Info

Publication number
IL127287A
IL127287A IL12728797A IL12728797A IL127287A IL 127287 A IL127287 A IL 127287A IL 12728797 A IL12728797 A IL 12728797A IL 12728797 A IL12728797 A IL 12728797A IL 127287 A IL127287 A IL 127287A
Authority
IL
Israel
Prior art keywords
aids
human
treatment
medicament
molecular crystals
Prior art date
Application number
IL12728797A
Other languages
English (en)
Other versions
IL127287A0 (en
Original Assignee
Marantech Holding Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marantech Holding Llc filed Critical Marantech Holding Llc
Publication of IL127287A0 publication Critical patent/IL127287A0/xx
Publication of IL127287A publication Critical patent/IL127287A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12728797A 1996-05-31 1997-05-29 Use of tetrasil ver tetroxide molecular crystals in the preparation of a medicament for treatment of aids IL127287A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/658,955 US5676977A (en) 1994-09-22 1996-05-31 Method of curing AIDS with tetrasilver tetroxide molecular crystal devices
PCT/US1997/009411 WO1997045133A1 (en) 1996-05-31 1997-05-29 Method of curing aids with tetrasilver tetroxide molecular crystal devices

Publications (2)

Publication Number Publication Date
IL127287A0 IL127287A0 (en) 1999-09-22
IL127287A true IL127287A (en) 2001-11-25

Family

ID=24643433

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12728797A IL127287A (en) 1996-05-31 1997-05-29 Use of tetrasil ver tetroxide molecular crystals in the preparation of a medicament for treatment of aids

Country Status (4)

Country Link
US (1) US5676977A (el)
EP (1) EP1024817A4 (el)
IL (1) IL127287A (el)
WO (1) WO1997045133A1 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258385B1 (en) 1999-04-22 2001-07-10 Marantech Holding, Llc Tetrasilver tetroxide treatment for skin conditions
US6436420B1 (en) * 2000-01-05 2002-08-20 Marantech Holding, Llc High performance silver (I,III) oxide antimicrobial textile articles
AU784593B2 (en) * 2000-01-06 2006-05-11 Marantech Holding, Llc Compositions and methods for facilitating skin growth and managing skin conditions
US20040022868A1 (en) * 2000-01-06 2004-02-05 Marantech Holding Llc Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
US6669966B1 (en) 2000-01-06 2003-12-30 Marantech Holding Llc Compositions for facilitating skin growth and methods and articles using same
US20060105057A1 (en) * 2000-01-06 2006-05-18 Marantech Holding, Llc Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
US6645531B1 (en) 2000-01-06 2003-11-11 Marantech Holding Llc Multivalent electron active compositions and methods of making and using same
US6485755B1 (en) 2000-01-06 2002-11-26 Marantech Holding Methods of using electron active compounds for managing cancer
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
RU2209072C2 (ru) * 2001-09-25 2003-07-27 Орловский Евгений Владимирович Антивирусная композиция для лечения вич-инфицированных больных с высокой вирусной нагрузкой
WO2003043537A1 (en) * 2001-11-19 2003-05-30 Marantech Holding Company, Llc Improvements in curing aids with tetrasilver tetroxide molecular crystal devices
WO2005030028A2 (en) * 2003-04-28 2005-04-07 Aidance Medical Diagnostics, Llc Methods for detecting presence of cellular constituents
CA2460585A1 (en) * 2003-05-16 2004-11-16 Exciton Technologies Inc. Deposition products, composite materials and processes for the production thereof
US9393261B2 (en) 2011-07-22 2016-07-19 Body Glide LLC Antimicrobial anti-chafing chelated silver oxide compound
US9132296B2 (en) 2007-05-17 2015-09-15 Ag Essence Antimicrobial solution and methods of making and using the same
AU2010314942B2 (en) * 2009-11-06 2016-11-10 Aidance Skincare & Topical Solutions Llc Improved silver oxide formulations
US11547116B2 (en) 2012-12-12 2023-01-10 William Wingfield Metal oxide compounds and infusion into polymer compounds
US11224227B2 (en) 2015-02-08 2022-01-18 Argaman Technologies Ltd. Antimicrobial material comprising synergistic combinations of metal oxides
CN107207771B (zh) * 2015-02-08 2019-12-06 阿尔贾曼技术有限公司 包含金属氧化物的协同组合的抗微生物材料

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415565A (en) * 1980-03-18 1983-11-15 The United States Of America As Represented By The Secretary Of The Army Silver metachloridine in treatment of infections
CH673225A5 (el) * 1986-04-22 1990-02-28 Sanosil Ag
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
US5073382A (en) * 1991-05-09 1991-12-17 N. Jonas & Co., Inc. Divalent silver alkaline bactericide compositions
US5078902A (en) * 1991-05-09 1992-01-07 N. Jonas & Co., Inc. Divalent silver halide bactericide
US5089275A (en) * 1991-05-09 1992-02-18 N. Jonas & Co., Inc. Stabilized divalent silver bactericides
US5336499A (en) * 1992-01-10 1994-08-09 Antelman Technologies, Ltd. Molecular crystal device for pharmaceuticals
US5211855A (en) * 1992-01-24 1993-05-18 N. Jonas & Co., Inc. Method of treating water employing tetrasilver tetroxide crystals
US5223149A (en) * 1992-05-18 1993-06-29 N. Jonas & Co., Inc. Trivalent silver water treatment compositions

Also Published As

Publication number Publication date
WO1997045133A1 (en) 1997-12-04
EP1024817A4 (en) 2000-09-20
US5676977A (en) 1997-10-14
EP1024817A1 (en) 2000-08-09
IL127287A0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
US5676977A (en) Method of curing AIDS with tetrasilver tetroxide molecular crystal devices
Toniato et al. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1
US5571520A (en) Molecular crystal redox device for pharmaceuticals
MacGarvey et al. Activation of mitochondrial biogenesis by heme oxygenase-1–mediated NF-E2–related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis
Griffiths et al. Haemoglobin-based blood substitutes and sepsis
Kawakami Interleukin-18 and host defense against infectious pathogens
Preis et al. Ceftriaxone alone or in combination with teicoplanin in the management of febrile episodes in neutropenic children and adolescents with cancer on an outpatient base
Pancoast et al. Clinical evaluation of piperacillin therapy for infection
Hummel et al. Suppression of Candida albicans by Escherichia coli
Shoemake et al. Efficacy of oral administration of sodium iodide to prevent bovine respiratory disease complex
Malmvall et al. Successful interferon-γ therapy in a chronic granulomatous disease (CGD) patient suffering from Staphylococcus aureus hepatic abscess and invasive Candida albicans infection
KR940702735A (ko) 조직 이식 수용자의 감염 치료를 위한 인터페론ㅡ감마(ifnㅡgamma)의 용도
Kirby Vancomycin therapy in severe staphylococcal infections
JP2712000B2 (ja) Ｃ型肝炎治療剤
Kosmidis et al. Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection
RU2364390C1 (ru) Фармацевтическая инъекционная композиция для лечения заболеваний с признаками иммунной недостаточности на основе тилорона
CN107320471B (zh) 一种治疗结核病的环丝氨酸药物组合物及其应用
Sekizawa et al. Amantadine and pneumonia in elderly stroke patients
CN107308147B (zh) 氨甲苯酸组合物在治疗结核病中的应用
HACKNEY et al. Clinical observations on viomycin sulphate in the treatment of tuberculosis
JPS62283935A (ja) 抗菌剤
Roe et al. Leucocyte responses of burned mice given mixed Gram-negative infections and treated topically with creams containing silver compounds
Sharma et al. Antibacterial product of peritoneal exudate cell cultures from guinea pigs infected with mycobacteria, listeriae, and rickettsiae
Shah et al. Nonmenstrual toxic shock syndrome in a young child with human immunodeficiency virus infection
SATO Prevention of serum hepatitis: effects of the PANS applied to transfused blood

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees